-
Xcell Biosciences Launches Technology Access Program
contractpharma
April 08, 2019
ImmunXperts named programs first partner
-
When a cell's 'fingerprint' can be a weapon against cancer
worldpharmanews
March 14, 2019
The study published in the scientific journal PLoS Computational Biology shows the types of tumors in which these genes are most active and identifies drugs with the potential to selectively eliminate cells that carry that label.
-
FDA announces new policies for cell and gene therapies
pharmaceutical-technology
January 17, 2019
Despite most of the US Food and Drug Administration’s (FDA) responsibilities grinding to a halt as a result of the US Government shut down ....
-
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
fiercepharma
January 09, 2019
Novartis' first-ever CAR-T cell therapy may have been hamstrung by early manufacturing problems, but the company still figures it can build a cell and gene therapy platform strong enough to deliver success not only with Kymriah but also a full "game board
-
Pfizer partners with CytoReason on immune system models for drug discovery
pharmaceutical-technology
January 09, 2019
Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in which the latter will leverage the former’s technology to create cell-based models of the immune system.....
-
Entrada emerges with $59M to fund the delivery of biologic therapies into the cell
fiercebiotech
December 25, 2018
Entrada Therapeutics has debuted with a $59 million series A and a plan to deliver biologic therapies intracellularly to treat rare and fatal monogenic diseases....
-
WuXi Biologics Advances Cell Culture Productivity
contractpharma
December 13, 2018
WuXi Biologics has advanced cell culture productivity for an Fc-fusion protein. The cell culture has a productivity of 2.5g/L/day and 51g/L bioreactor volume in a 20-day continuous cell culture process called WuXiUP (Ultra-high Productivity).
-
Cell-derived flu strain provides a better match than eggs: study
fiercepharma
December 04, 2018
Flu vaccine efficacy problems were well documented throughout last year’s harsh season. Now the world’s largest cell-based vaccine producer...
-
Korea approves Opdivo-Yervoy for renal cell carcinoma treatment
biospectrumasia
September 29, 2018
The approval is based on a clinical trial called CheckMate-214.
-
SMi presents the launch of Cell & Gene Therapy 2018
worldpharmanews
May 23, 2018
SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October.